Foxp3 and IL-10 expression correlates with parasite burden in lesional tissues of post kala azar dermal leishmaniasis (PKDL) patients

PLoS Neglected Tropical Diseases

Volumn 5, Issue 5, 2011, Pages

  Katara, Gajendra Kumar ^a   Ansari, Nasim Akhtar ^a,c   Verma, Sandeep ^a   Ramesh, V ^b   Salotra, Poonam ^a  

^a SAFDARJUNG HOSPITAL CAMPUS   (India)

^b SAFDARJUNG HOSPITAL   (India)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR ALPHA; MESSENGER RNA; MILTEFOSINE; TRANSCRIPTION FACTOR FOXP3; CYTOTOXIC T-LYMPHOCYTE ANTIGEN 4; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; IL10 PROTEIN, HUMAN; IL2RA PROTEIN, HUMAN; LEUKOCYTE ANTIGEN;

ADULT; ARTICLE; CELL AGGREGATION; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; EX VIVO STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; NONHUMAN; PARASITE LOAD; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; SKIN LEISHMANIASIS; ANIMAL; CHEMISTRY; GENE EXPRESSION PROFILING; GENETICS; IMMUNOLOGY; ISOLATION AND PURIFICATION; LEISHMANIA DONOVANI; MIDDLE AGED; PARASITOLOGY; PATHOLOGY; SKIN; VISCERAL LEISHMANIASIS;

ADULT; ANIMALS; ANTIGENS, CD; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION PROFILING; HUMANS; INTERLEUKIN-10; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LEISHMANIA DONOVANI; LEISHMANIASIS, CUTANEOUS; LEISHMANIASIS, VISCERAL; MALE; MIDDLE AGED; RNA, MESSENGER; SKIN; T-LYMPHOCYTES, REGULATORY;

EID: 79957993220     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0001171     Document Type: Article

References (24)

1. Guerin PJ, Olliaro P, Sundar S, Boelaert M, Croft SL, et al. (2002) Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda. Lancet Infect Dis 2: 494-501.
2. Zijlstra EE, Musa AM, Khalil EAG, EI-Hassan IM, EI-Hassan AM, (2003) Post kala azar dermal leishmaniasis. Lancet Infect Dis 3: 87-98.
3. Saha S, Mondal S, Ravindran R, Bhowmick S, Modak D, et al. (2007) IL-10 and TGF-beta-mediated susceptibility in Kala-azar and Post-kala-azar dermal Leishmaniasis: the significance of amphotericin B in the control of Leishmania donovani infection in India. J Immunol 179: 5592-5603.
4. Ansari NA, Ramesh V, Salotra P, (2006) Interferon (IFN)-gamma, tumor necrosis factor-alpha, interleukin-6, and IFN-gamma receptor 1 are the major immunological determinants associated with post-kala azar dermal leishmaniasis. J Infect Dis 194: 958-965.
5. Verma S, Kumar R, Katara GK, Singh LC, Negi NS, et al. (2010) Quantification of parasite load in clinical samples of leishmaniasis patients: IL-10 level correlates with parasite load in visceral leishmaniasis. PLoS ONE 5 (4): e10107 doi10.1371/journal.pone.0010107.
6. Nylén S, Maurya R, Eidsmo L, Manandhar KD, Sundar S, et al. (2007) Splenic accumulation of IL-10 mRNA in T cells distinct from CD4+CD25+ (Foxp3) regulatory T cells in human visceral leishmaniasis. J Exp Med 204: 805-817.
7. Murray HW, Lu CM, Mauze S, Freeman S, Moreira AL, et al. (2002) Interleukin-10 (IL-10) in experimental visceral leishmaniasis and IL-10 receptor blockade as immunotherapy. Infect Immun 70: 6284-6293.
8. Belkaid Y, Piccirillo CA, Mendez S, Shevach EM, Sacks DL, (2002) CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature 420: 502-507.
9. Campanelli AP, Roselino AM, Cavassani KA, Pereira MS, Mortara RA, et al. (2006) CD4+CD25+ T cells in skin lesions of patients with cutaneous leishmaniasis exhibit phenotypic and functional characteristics of natural regulatory T cells. J Infect Dis 193: 1313-1322.
10. Bourreau E, Ronet C, Darsissac E, Lise MC, Marie DS, et al. (2009) In Leishmaniasis due to Leishmania guyanensis infection, distinct intralesional interleukin-10 and Foxp3 mRNA expression are associated with unresponsiveness to treatment. J Infect Dis 199: 576-579.
11. Baecher-Allan C, Brown JA, Freeman GJ, Hafler DA, (2001) CD4+CD25 high regulatory cells in human peripheral blood. J Immunol 167: 1245-1253.
12. Ismail A, Gadir AF, Theander TG, Kharazmi A, El Hassan AM, (2006) Pathology of post-kala-azar dermal leishmaniasis: a light microscopical, immunohistochemical, and ultrastructural study of skin lesions and draining lymph nodes. J Cutan Pathol 33: 778-787.
13. Kumar R, Bumb RA, Salotra P, (2009) Correlation of parasitic load with interleukin-4 response in patients with cutaneous leishmaniasis due to Leishmania tropica. FEMS Immunol Med Microbiol 57: 239-246.
14. Miralles GD, Stoeckle MY, McDermott DF, Finkelman FD, Murray HW, (1994) Th1 and Th2 cell-associated cytokines in experimental visceral leishmaniasis. Infect Immun 62: 1058-1063.
15. Walther M, Tongren JE, Andrews L, Korbel D, King E, et al. (2005) Upregulation of TGF-beta, FOXP3, and CD4+CD25+ regulatory T cells correlates with more rapid parasite growth in human malaria infection. Immunity 23: 287-296.
16. Linsley PS, Greene JL, Brady W, Bajorath J, Ledbetter JA, et al. (1994) Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors. Immunity 1: 793-801.
17. Lindsten T, Lee KP, Harris ES, Petryniak B, Craighead N, et al. 1993 Characterization of CTLA-4 structure and expression on human T cells. J Immunol 151: 3489-3499.
18. Alegre ML, Frauwirth KA, Thompson CB, (2001) T-cell regulation by CD28 and CTLA-4. Nat Rev Immunol 1: 220-228.
19. Ganguly S, Mukhopadhyay D, Das NK, Chaduvula M, Sadhu S, et al. (2010) Enhanced lesional Foxp3 expression and peripheral anergic lymphocytes indicate a role for regulatory T cells in Indian post-kala-azar dermal leishmaniasis. J Invest Dermatol 130: 1013-1022.
20. Murphy ML, Cotterell SE, Gorak PM, Engwerda CR, Kaye PM, (1998) Blockade of CTLA-4 enhances host resistance to the intracellular pathogen, Leishmania donovani. J Immunol 161: 4153-4160.
21. Gasim S, Elhassan AM, Khalil EA, Ismail A, Kadaru AM, et al. (1998) High levels of plasma IL-10 and expression of IL-10 by keratinocytes during visceral leishmaniasis predict subsequent development of post-kala-azar dermal leishmaniasis. Clin Exp Immunol 111: 64-69.
22. Murai M, Turovskaya O, Kim G, Madan R, Karp CL, et al. (2009) Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis. Nat Immunol 10: 1178-1184.
23. Rathi SK, Pandhi RK, Chopra P, Khanna N, (2005) Post kala azar dermal leishmaniasis: A histopathological study. Indian J Dermatol Venereol Leprol 71: 250-253.
24. Mukherjee A, Ramesh V, Misra RS, (1993) Post-kala-azar dermal leishmaniasis: A light and electron microscopic study of 18 cases. J Cutan Pathol 20: 320-325.